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Background: Improvements in asthma diagnosis and management require deeper understanding of the
heterogeneity of the complex airway inflammation. We hypothesise that differences in the two major inflammatory
phenotypes of asthma; eosinophilic and neutrophilic asthma, will be reflected in the lung protein expression profile
of murine asthma models and can be delineated using proteomics of bronchoalveolar lavage (BAL).
Methods: BAL from mice challenged with ovalbumin (OVA/OVA) alone (standard model of asthma, here
considered eosinophilic) or OVA in combination with endotoxin (OVA/LPS, model of neutrophilic asthma) was
analysed using liquid chromatography coupled to high resolution mass spectrometry, and compared with
steroid-treated animals and healthy controls. In addition, conventional inflammatory markers were analysed using
multiplexed ELISA (Bio-Plex™ assay). Multivariate statistics was performed on integrative proteomic fingerprints using
principal component analysis. Proteomic data were complemented with lung mechanics and BAL cell counts.
Results: Several of the analysed proteins displayed significant differences between the controls and either or both
of the two models reflecting eosinophilic and neutrophilic asthma. Most of the proteins found with mass
spectrometry analysis displayed a considerable increase in neutrophilic asthma compared with the other groups.
Conversely, the larger number of the inflammatory markers analysed with Bio-Plex™ analysis were found to be
increased in the eosinophilic model. In addition, major inflammation markers were correlated to peripheral airway
closure, while commonly used asthma biomarkers only reflect central inflammation.
Conclusion: Our data suggest that the commercial markers we are currently relying on to diagnose asthma
subtypes are not giving us comprehensive or specific enough information. The analysed protein profiles allowed to
discriminate the two models and may add useful information for characterization of different asthma phenotypes.
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Asthma is a heterogeneous airway inflammation which
gives rise to several different clinical phenotypes. The
phenotypes are traditionally classified according to their
inflammatory profiles; eosinophilic asthma (EA), neutro-
philic asthma (NA), mixed granulocytic asthma (MGA)
and paucigranulocytic asthma (PGA) [1]. However, the
disease relevant biochemistry underlying the differenti-
ation of phenotypes remain unexplained and further* Correspondence: jorg.hanrieder@chalmers.se
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vance treatment.
Murine asthma models have been developed to mimic
the two major subtypes of asthma, EA and NA. This has
been achieved by intraperitoneal injections of ovalbumin
(OVA) followed by either nebulization of OVA alone
into the airways resembling the EA subtype, or adding
nebulised endotoxin (lipopolysaccharide, LPS) together
with OVA to create a neutrophilic airway inflammation
[2-4]. The additional LPS exposure reflects a more se-
vere form of experimental asthma, as it enhances the
number of cells in bronchoalveolar lavage (BAL) and
increases neutrophil recruitment, whereas the numberral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Schematic outline of the animal experiments. Two
groups, resembling eosinophilic (A) and neutrophilic asthma (B),
were subjected to sensitization via i.p. injection and challenge
through inhalation of ovalbumin (OVA). For the neutrophilic asthma
model, animals were additionally challenged with lipopolysaccharide
(LPS). A third group of animals in the neutrophilic asthma group,
received steroid (GC) treatment 1 h prior challenge and lung
mechanic assessment. As controls a final fourth group, received only
vehicle (PBS) treatment during inhalation. Lung function testing was
performed for all groups at day 17 followed by BAL fluid collection,
differential cell count and proteomic analysis.
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[2] and reduced [3]. Longitudinal in-depth investiga-
tions of related clinical specimen, such as BAL and
lung tissue, represent a promising strategy to further
elucidate the molecular pathology of these two asthma
phenotypes. While common biochemical techniques
have been the standard approach in molecular analysis
of clinical samples, more powerful methodological ap-
proaches are needed to delineate molecular signatures
in such complex biological systems.
Mass spectrometry based proteomics allows compre-
hensive and sensitive profiling of the protein expression
pattern in biological samples [5]. We hypothesised that
the pathogenic mechanisms underlying these asthma
models would be reflected in the protein pattern in BAL.
To this end, we therefore employed an integrated ap-
proach combining mass spectrometry-based protein ana-
lysis together with screening of a multiplex array of
inflammatory biomarkers, in BAL in experimental asthma.
Methods
Animals
Female BALB/c mice (Taconic M&B, Denmark) were
used in this study. They were housed in plastic cages
with absorbent bedding material and were maintained
on a 12 h daylight cycle. Food and water were provided
ad libitum. Their care and the experimental protocols
were approved by the Regional Ethics Committee on
Animal Experiments in Uppsala (C86/5 and C64/8). Mice
were 6–7 weeks of age when the airway inflammation
protocol started and 9–10 weeks when BAL was collected
(n = 5-6 mice per group).
Asthma models
For the eosinophilic asthma group (OVA, n = 5), airway
inflammation was induced as described previously [3] by
intraperitoneal (i.p.) injections of 10 μg ovalbumin (OVA,
Sigma-Aldrich, St. Louis, MO, USA) emulsified in Al(OH)
3 (Sigma) on day 0 and day 7. The animals were then in-
haled aerosolised 1% OVA diluted in phosphate-buffered
saline (PBS, Sigma) for 30 min on days 14–16 (Figure 1).
The aerosol exposure was performed in a chamber
coupled to a nebuliser (DeVilbiss UltraNeb®, Sunrise
Medical Ltd, U.K.). The chamber was divided into pie-
shaped compartments with individual boxes for each
animal, providing equal and simultaneous exposure to the
allergen. A second group of mice (n = 6), resembling neu-
trophilic asthma, received i.p. OVA and was exposed to in-
haled aerosolised LPS (Escherichia coli serotype 0111:
B4; Sigma) dissolved in ddH2O) diluted in PBS sim-
ultaneously with OVA as described above on days 14–16
(Figure 1). The concentration of LPS in the nebuliser was
0.005% w/v (the OVA+ LPS group). A third group (n = 5)
received glucocorticoid (GC) treatment (hydrocortisonesodium succinate, 0.375 g/kg) immediately before OVA +
LPS challenge (days 14–16). Finally, a group of mice
(n = 5) served as control (C) with no exposure to any
known airway irritant and was treated with vehicle
(PBS).
Lung mechanics and airway responsiveness
Dynamic lung mechanics were evaluated as described in
detail elsewhere [3]. Briefly, airway reactivity was charac-
terised by murine ventilator and forced oscillation tech-
nique (FOT) where Newtonian resistance (RN), tissue
damping (G) and elastance (H) were determined. Airway
responsiveness was determined by investigating the max-
imal response of G, H, an RN upon intravenous methacho-
line (MCh) injection in incremental doses (0 (PBS), 0.03,
0.1, 0.3, 1, and 3 mg/kg). MCh (acetyl-β-methylcholine
chloride, Sigma Aldrich) was diluted in PBS (Sigma Aldrich)
with 10U/mL heparin. The volume of MCh solution was
adjusted to 2 mL/kg that were injected for each dose.
BAL collection and cell count
Mice were subjected to BAL via the tracheal tube
(0.6 mM EDTA/PBS). BAL fluid was centrifuged, the
cell pellet subjected to erythrolysis followed by cell
count and cytospin preparations (50 000 cells, Shandon
Cytospin 3) stained with May-Grünwald-Giemsa reagent.
Differential cell counts of pulmonary inflammatory cells
were made with standard morphological criteria counting
300 cells per cytospin preparation (Figure 2).
Proteomic profiling
Protein digestion
The total protein concentration in the different BAL
samples was determined using a Bradford assay (Protein
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Figure 2 Lung Mechanics: Airway responsiveness was evaluated using forced oscillation technique (FOT) [Prime 2 perturbation, resp.
system impedance (Zrs) measurements]. (A,B) Measurements of methacholine (MCh) induced tissue damping (G, A) and elastance (H, B). The
maximum MCh response (3 mg/kg) was measured in controls (PBS), OVA/OVA challenged group, OVA/LPS challenged group and OVA/LPS
challenged mice that received steroid treatment (OVA/LPS/GC). Values are indicated as mean ± SE.*p < 0.05 (C vs OVA/OVA and C vs OVA/LPS);
#p < 0.05 (OVA/LPS vs OVA/LPS/GC); (B) p = 0.06 (C vs OVA/LPS); (C) Measurements of methacholine (MCh) induced Newtonian resistance (RN) for
different MCh doses (mg/kg). Values are indicated as mean ± SE. ǂ,*,§: p < 0.05; §§: p < 0.01 (C vs OVA/LPS); §§§: p < 0.001 (C vs OVA/LPS); The
control data have been published previously [4].
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ised to a total protein amount of 50 μg. A volume of 50 μL
denaturation buffer (8 M urea, 400 mM NH4HCO3,
Sigma) was added, followed by the addition of 10 μL DTT
(45 mM, Sigma) and incubation at 55°C for 15 min for
protein reduction. For alkylation a volume of 10 μL IAA
(100 mM, Sigma) was added followed by incubation at
25°C in darkness. 25 μg sequence grade trypsin from
bovine pancreas (Roche, Basel, Switzerland) were recon-
stituted in 250 μL ddH2O to give a final concentration
of 100 ng/μL. A volume of 20 μL Trypsin solution (2 μg,
1:25 w:w) was added to the protein solution and incubated
at 37°C overnight. The samples were desalted on ZipTip®
C18 columns (Millipore, Bedford, MA, USA), according
to manufactures instructions. The collected peptide frac-
tions were dried down under reduced pressure (ThermoSavant SpeedVac, Thermo Scientific, Hercules, MA, USA)
and reconstituted in 10 μL 0.1% formic acid (FA).
LC –ESI MS/MS
The tryptic peptide samples were analysed in duplicates
on an Agilent 1100 nanoflow system (Agilent Technolo-
gies, Santa Clara, CA, USA) hyphenated to a LTQ-FT
7.0 T electrospray linear iontrap/Fourier transform ion
cyclotron resonance MS hybrid instrument (Thermo). A
volume of 5 μL from the reconstituted digests was
injected automatically and loaded onto a in-house packed
C18 PicoFrit column (75 μm ID/15 μm tip ID, NewObjec-
tive, Woburn, MA, USA) packed directly inside the
electrospray needle tip using specially designed nanos-
pray emitter tips. A water/formic acid/acetonitrile solv-
ent system was used where solvent A was 0.1% FA and
Table 1 Overview of protein species identified with
quantitative proteomics that displayed significant
changes in between different groups
Protein species Database annotation1
Protein S100-A9 S10A9_MOUSE
Complement Factor B CFAB_MOUSE
Phosphoglycerate mutase 1 PGAM1_MOUSE
Regenerating islet-derived protein 3-gamma REG3G_MOUSE
Plasminogen PLMN_MOUSE
Ig gamma-1 chain C, membrane-bound form IGH1M_MOUSE
Pulmonary surfactant-associated protein SFTPD_MOUSE
Plastin 2 PLSL_MOUSE
Polymeric immunoglobulin receptor PIGR_MOUSE
C-X-C motif chemokine 15 CXL15_MOUSE
Tubulin polymerization-promoting protein 3 TPPP3_MOUSE
Copper transport protein ATOX1 ATOX1_MOUSE
Ceruloplasmin CERU_MOUSE
Histone H2B type 1-A H2B1A_MOUSE
Immunoglobulin J chain IGJ_MOUSE
Serum albumin ALBU_MOUSE
Serine protease inhibitor A3K SPA3K_MOUSE
Eosinophil cationic protein 2 ECP2_MOUSE
Complement C3 CO3_MOUSE
Chitinase-3-like protein 3 CH3L3_MOUSE
Fibronectin FINC_MOUSE
Resistin-like alpha RETNA_MOUSE
Malate dehydrogenase, cytoplasmic MDHC_MOUSE
Serine protease inhibitor A3N SPA3N_MOUSE
Cathelin-related antimicrobial peptide CRAMP_MOUSE
Glutathione reductase, mitochondrial GSHR_MOUSE
Peptidoglycan recognition protein 1 PGRP1_MOUSE
Glyceraldehyde-3-phosphate dehydrogenase G3P_MOUSE
Carbonyl reductase [NADPH] 2 CBR2_MOUSE
Histone H4 H4_MOUSE
14-3-3 protein epsilon 1433E_MOUSE
Proteins significantly identified by mass spectrometry based proteomics (p < 0.05)
that were found significantly changed (p < 0.05, ANOVA) in between at least 2
groups. 1Protein annotation according to the uniprot knowledgebase
(v.56, www.uniprot.org).
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performed from 0% B for 10 min, then from 0% B to 50%
B for 100 min, then from 50% B to 90% B for 5 min, then
90% B for 5 min and finally from 90% B back to 0% B for
5 min. Peptide elution was followed by ESI FTICR MS
and tandem mass spectrometry (MS/MS) for peptide se-
quencing controlled by the Xcalibur software (v.2.0 SR2,
Thermo). Fullscan spectra were acquired at high reso-
lution (FWHM= 100000) using the FT analyser. Data
dependent acquisition was applied for MS/MS precursor
selection, where the 5 most intense mass peaks were sub-
jected to subsequent isolation and collision-induced frag-
mentation in the ion trap. Acquired raw data were
exported to an *.mgf file using an in-house written script
(C++). The annotated fragment spectra were subjected to
database search using, the Mascot search engine (v.2.2,
Matrix Science, London, UK) (5). Mascot searches were
performed against the Uniprot knowledgebase (v.56, www.
uniprot.org) using the following specifications: mass toler-
ance (MS: ±10 ppm, MS/MS: ±0.9 Da) enzyme (trypsin),
fixed modifications (carbamidomethyl), variable modifica-
tions (oxidation of Met), precursor charge (1+,2+,3+) and
instrument (ESI-TRAP). Peptide matches with a score
above the confidence threshold (p < 0.05) were considered
to be a significant hit. A minimum number of 2 peptides
per proteins were required. The false positive identifica-
tion rate (FPR) was estimated by searching the data
against a decoy database. Database searches were refined
by narrowing the mass tolerance and only protein findings
at a FPR <1% were considered.
Protein quantification
The database search results were exported as *.dat files
and loaded into the Scaffold software (v.3.1.2, Proteome
Software, Portland, OR) together with the corresponding
protein sequence data file of the current uniprot database
(v.56, *.fasta file, taxonomy: mouse; www.uniprote.org).
Quantification was performed according to the normal-
ised spectral count of each protein species (SIN) [5].
Relative protein intensities in each biological replicate
were subjected to global statistical analysis (ANOVA,
p < 0.05) to reveal significant differences in between
the different groups using the corresponding function
implemented in the software. The quantitation results
were exported to MS Excel (v.2010) for further statis-
tical evaluation.
Multiplexed ELISA analysis
Inflammatory mediators in BAL were analysed for the
presence of 23 cytokines and chemokines (Bio-Plex™ Pro
Mouse Cytokine 23-plex panel, BioRad, Hercules, CA,
USA) (Table 1). The analysis was performed in duplicates
on a Bio-Plex™ system (Luminex Bio-Plex™ 200 System,
Bio-Rad) according to the manufacturer’s instructions.Data analysis and statistics
For proteins that exhibited changes in concentration as
revealed by label free quantitative proteomics, intensity
values were pooled with Bio-Plex™ protein concentration
data. The protein concentration data were mean centred
and autoscaled prior subjection to principal component
analysis using the pcamethods script (www.bioconductor.
org) in R (www.R-project.org). For all individual protein
species, ANOVA was performed followed by Tukey posthoc
analysis (origin v.8.1, originlab, Northampton, MA, USA).
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Characterization of the experimental asthma models
For characterization of lung mechanics and airway reactiv-
ity, a murine ventilator and forced oscillation technique
(FOT) was employed. This approach allowed to calculate
respiratory system input impedance that in turn allows the
lung mechanics to be divided into central and peripheral
components as described previously [3,6]. This included
Newtonian resistance (RN) as primary central parameter;
and tissue damping (G) and elastance (H) as peripheral
parameters (Figure 2) [3,6].
At maximum dose MCh (3 mg/kg), tissue damping
(G) was increased in both OVA/OVA and OVA/LPS
compared to controls (p < 0.05). Tissue damping was in-
creased in OVA/OVA compared to OVA/LPS, although
not significant (p = 0.07). Steroid treatment (OVA/LPS/
GC) reduced G (p < 0.01) as compared to the OVA/LPS
group (Figure 2A). Upon MCh injection at maximum
dose (3 mg/kg), elastance (H) was increased in OVA/
OVA (p < 0.05) and OVA/LPS (p = 0.06) compared to
control animals. H was furthermore significantly de-
creased (p < 0.05) upon GC treatment (OVA/LPS/GC)
compared to OVA/LPS mice (Figure 2B). MCh induced
bronchoconstriction (RN) was increased in both asthma
models compared to controls (p < 0.05) for the maximum
MCh dose. Similarly, RN was significantly decreased with
steroid treatment (Figure 2C). No significant changes
were observed for MCh induced Newtonian resistance in
between OVA/OVA and OVA/LPS mice.
Lung mechanics were complemented with total BAL
cell count for inflammatory cells including eosinphils
(Eos), macrophages (Mac), neutrophils (Neu) and lympho-
cytes (Lym) for each treatment group. Here, a significantFigure 3 Total cell count for inflammatory cells (mean ± SEM) includin
lymphocytes (Lym) for each treatment group. Non-parametric ANOVA (
OVA/OVA as well as C and OVA/LPS group for total cell counts, eosinophils,
difference was observed for lymphocytes (*p < 0.05). Significant difference
neutrophils (& p < 0.05) as well as a strong trend (p = 0.0504) for eosinophi
observed in between OVA/OVA and OVA/LPS (#p < 0.05). The control data hincrease of total cell counts, eosinophils, macrophages and
neutrophils was observed between control and OVA/OVA
as well as C and OVA/LPS group for (p < 0.05).
Furthermore, an increase of macrophage and neutrophil
numbers (p < 0.05) was observed in OVA/LPS challenged
mice compared to the OVA/OVA group. In addition,
macrophages and neutrophil numbers were decreased
in steroid treated mice (OVA/LPS/GC group) compared
to OVA/LPS mice (p < 0.05) (Figure 3). Furthermore,
eosinophil numbers were decreased in OVA/LPS/GC
compared to OVA/LPS, although this was a strong trend
(p = 0.0504), this decrease was not significant. Lymphocyte
numbers did not display a change in between the different
treatment groups.
Differential BAL proteome profiling in experimental
asthma
Comprehensive proteomic profiling of BAL using nanoLC-
ESI FTICR MS/MS yielded 176 significant and unique
protein species that were identified consistently in all 30
BAL samples (Additional file 1: Table S1). In order to de-
termine protein functionalities, all proteomic data were
mapped according to the individual molecular function
and biological process using the PANTHER (Protein
ANalysis THrough Evolutionary Relationships) Classi-
fication System [7], a part of the gene ontology project.
A large part of the detected protein species were found
to be involved in immune response (Figure 4B) as well
as rather general processes such as cell communica-
tion, metabolism and transport (Figure 4A). In detail,
the proteins had a wide variety of different functional-
ities, including binding, catalytic and enzymatic activ-
ity (Figure 4B).g eosinphils (Eos), macrophages (Mac), neutrophils (Neu) and
Kuskal Wallis) revealed statistical significance between Controls (C) and
macrophages and neutrophils (*p < 0.05). For C vs GC significant
between OVA/LPS and GC group was observed for macrophages and
ls. For macrophages and neutrophils significant difference were
ave been published previously [4].
Figure 4 Protein function and relevance in various biological processes as determined by PANTHER/Gene Ontology analysis. (A) Gene
ontology map of detected protein species: molecular function (read clockwise starting at 1 = red to 10 = green). (B) Gene ontology map of
detected protein species: biological process (read clockwise starting at 1 = green to 15 = pink).
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(SIN) of all identified protein species revealed significant
changes in protein intensities between the different groups.
Statistical analysis (ANOVA, Tukey posthoc) showed
significant changes for 28 protein species (p < 0.05,
Table 1, Additional file 2: Figure S1). Due to the dy-
namic concentration range, detection of chemokines
using LC-MS based proteomics is difficult and requires
targeted approaches such as ELISA. Therefore the aim
was to complement the proteomic data with a standard
panel of well-known chemokines that are of established
relevance in airway inflammation. Here, complementary
multiplexed ELISA (Bio-Plex™) analysis added infor-
mation about common inflammatory markers in the
groups (Table 2). Of the 23 measured chemokines, a
number of 17 were significantly changed in between the
different groups (p < 0.05; Additional file 2: Figure S2).
Multivariate data analysis of integrative proteomic
fingerprints
For further data analysis by means of multivariate statis-
tics, the proteomics data as well as the Bio-Plex™ data were
combined in a single data matrix and subjected to princi-
pal component analysis (PCA). The results show distinctclustering of the individual samples according to their
respective group (Figure 5A). Inspection of the corre-
sponding loadings enabled for deduction of the individ-
ual variables (protein intensities) that had the greatest
influence on the corresponding PC score for each indi-
vidual sample. The PC score based clustering behaviour
is reflected in the corresponding loadings and therefore
based on similar changes of the protein intensities that
relate to these loadings (Figure 5B). This reveals the in-
dividual protein species that show similar changes based
on different models and allow differentiation of the in-
dividual samples based on their multivariate pattern.
Altered protein expression in different subtypes of
experimental asthma and GC treatment
Inspection of the variables (loadings, proteins) as obtained
by multivariate analysis, revealed group specific protein
regulation patterns (Figure 5B). These results were com-
pared to univariate statistical analysis (ANOVA). Many
proteins displayed significant differences between the con-
trols and either or both of the two models reflecting EA
and NA (Figure 6, Additional file 2: Figure S1 and S2).
The major number of proteins were found to be only
slightly or not at all increased in EA (OVA) compared to
Table 2 Overview of Protein species included in the
Bio-Plex™ panel for multiplexed ELISA
Protein name Abbreviation
Interleukin 1a IL-1a*
Interleukin 1b IL-1b*
Interleukin 2 IL-2*
Interleukin 3 IL-3*
Interleukin 4 IL-4
Interleukin 5 IL-5
Interleukin 6 IL-6
Interleukin 9 IL-9*
Interleukin 10 IL-10
Interleukin 12 p40 IL-12(p40)*
Interleukin 12 p70 IL-12(p70)
Interleukin 13 IL-13*
Interleukin 17 IL-17*
Eotaxin Eotaxin*
Granulocyte colony-stimulating factor G-CSF
Granulocyte-macrophage colony-stimulating factor GM-CSF*
Interferon gamma IFN-γ*
Chemokine (C-X-C motif) ligand 1 KC*
Monocyte chemotactic protein-1) MCP-1*
Macrophage Inflammatory Protein 1a MIP-1a*
Macrophage Inflammatory Protein 1b MIP-1b*
Chemokine (C-C motif) ligand 5 RANTES*
Tumor necrosis factor alpha TNFα*
*Marked species were significantly (p < 0.05) changed in between at least 2
groups.
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LPS-induced) compared to all other groups (Figure 6).
These included mainly acute phase reactants, such as
S100 calcium binding protein A9 (calgranulin B/S100-A9),
complement CO3 (CO3), complement factor B (CFAB),
immunoglobulins IG-J and IG-H as well as histones (H2
and H4) and phosphoglycerate mutase (PGAM1). Fur-
thermore, similar trends were observed for proteins of
potential relevance in the respiratory system, including
eosinophil cationic protein (ECP2), lung polymeric im-
munoglobulin receptor (PIGR) and pulmonary surfac-
tant protein D (SFTPD) (Additional file 2: Figure S1).
Pro-inflammatory markers Monocyte Chemotactic Pro-
tein 1 (MCP1) and Regulated upon activation normal T
cell expressed and presumably secreted (RANTES) de-
tected in the Bio-Plex™ analysis panel showed a marked
elevation in the LPS group (Additional file 2: Figure S2).
A number of protein species were found increased in
both asthma models. Eosinophil cationic protein 2 (ECP2),
resistin A (RETNA), fibronectin (FINC) and chitinase 3
(CH3L3) exhibited a higher intensity in the NA comparedto the EA model, but were increased in EA compared to
controls and glucocorticoid-treated animals (Additional
file 2: Figure S1). The same trend was found for MIP-1α
and β, as well as interleukins IL-4, IL-12p40, and IL-17A.
Conversely, IL-1β, IL-2, IL-5, IL-10 and keratinocyte
chemo-attractant (KC) were elevated in both models
but higher in EA compared to NA (Additional file 2:
Figure S2). Finally, five protein species including regenerat-
ing islet-derived protein 3 (REG3), tubulin polymerization
promoting protein (TPPP), IL-3, eotaxin and interferon
gamma (IFN-γ) were found solely elevated in the EA group
and not in the NA group (Additional file 2: Figure S1
and S2). Proteins found in control mice that were nega-
tively regulated by airway inflammation and recovered
after glucocorticoid treatment was malate dehydrogenase
(MDHC) and serine protease inhibitor 3 (SPA3N). Plas-
minogen (PLMN) was decreased both in the EA and the
NA groups, but was not recovered by steroid treatment
(Figure 6, Additional file 2: Figure S1 and S2).
Correlation between specific proteins and inflammatory
cells
Linear regression analysis was performed for all signifi-
cant protein species and the total cell count for inflam-
matory leucocytes (Table 3). Here, positive correlations
were observed for the neutrophil count with acute phase
reactants (S100-A9), immunoglobulins (IGH1M, PIGR),
metabolic enzymes (PGAM) as well as other multifunc-
tional proteins including actin-binding protein plastin 2
(PLSL), fibronectin (FINC), CRAMP and PGRP1. Eosin-
ophils were found to correlate positively with cytokines
IL-9 and IFN-γ, as well as eotaxin and carbonyl reductase
2 (CBR2). Lymphocyte count correlated positively with
IGHM1, PIGR and FINC, but interestingly, was found
to correlate negatively with CBR2. Macrophage count
displayed positive correlations with S100-A9, CFAB, cy-
tokines (IL-12p40, IL-13, GM-CSF, MIP-1b, TNF), che-
mokines (CXCL-15, CH3L3), binding proteins (PLSL,
H2B1A and H4), immunoglobulins (IGJ, IGH1M),
cytotoxic protein ECP2, adaptor protein 1433e, pep-
tidoglycan recognition protein PGRP1, antimicrobial
peptide CRAMP, and mitochondrial protein GSHR.
The anticoagulant and proteolytic factor plasmino-
gen (PLMN) displayed a negative correlation with
macrophages.
Correlation between specific proteins and lung mechanics
Correlation analysis of individual protein concentra-
tion values obtained from both proteomic strategies
(LCMS and Bioplex) and lung mechanics data were
performed for each animal. Here, peripheral lung me-
chanics parameters; elastance (H) and tissue damping
(G) were found to correlate positively with inflamma-
tory markers (S100-A9, RANTES), immunoglobulins
PC 1
PCA Score Plot
PC
 2
 
PCA Loading Plot
PC 1
PC
 2
 
A 
B 
Figure 5 Statistical discrimination of different experimental asthma models and glucocorticoid treatment. Multivariate analysis by means
of principal component analysis (PCA) of all group specific protein concentration levels allowed clear separation of the different samples
according to their treatment group (A). The corresponding loading plot shows the loading of each variable (protein concentration) on the score
for each individual sample. This in turn allows deducing what protein species impact the sample scores and their clustering behaviour (B).
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as other functional proteins including actin-binding
protein plastin 2 (PLSL), fibronectin (FINC), CRAMP,
PGRP1 (only G) and interleukins: IL12p40 and IL17
(only G) (Table 4). Newtonian resistance (RN) as cen-
tral lung mechanic parameter was found to correlate
negatively with serine protease inhibitor (SPA3K) and
carbonyl reductase (CBR2). Conversely, positive corre-
lations were obtained in between RN and chitinase
(CH3L3) as well as interleukins: IL5, IL12p40 and IL13
(Table 4).Discussion
Over the last decade, proteomic based mapping of the
protein expression profiles of complex biological samples
has been well established for getting a comprehensive mo-
lecular insight in biological processes underlying disease
pathology. To our knowledge, this is the first study on
quantitative proteomic profiling of lung-derived specimen
in experimental eosinophilic and neutrophilic asthma. We
hypothesised that protein expression patterns of BAL fluid
would reflect the mechanistic differences between asthma
phenotypes. In this study, we therefore investigated BAL
0 100%
Luminex Proteomics
C
OVA/OVA
OVA/LPS
GC
Figure 6 Protein changes in different experimental models of asthma (OVA and OVA + LPS) as well as glucocorticoid treated animals
(GC) and controls (C). Heat map showing protein quantification results (mean SIN, n = 5-6) detected by MS based proteomics and Bio-Plex™. The
data are normalised to the total intensity as indicated by the intensity scale.
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http://www.biomedcentral.com/1471-2466/14/110proteome dynamics from experimental eosinophilic and
neutrophilic asthma using an integrated proteomics ap-
proach based on high resolution mass spectrometry and
multiplexed ELISA.
We demonstrated that the protein expression levels of
several acute phase proteins such as S100-A9, comple-
ments (CO3, CFAB) and immunoglobulins (IGJ, IGH,
PIGR) were increased in the BAL from mice with OVA+
LPS-induced airway inflammation compared to mice
with OVA-induced airway inflammation, and that these
up regulations could be nearly completely averted by
pre-treatment with glucocorticoid therapy (Additional
file 2: Figure S1 and S2). Our major findings show that
the eosinophilic (OVA-induced) and the neutrophilic
(OVA + LPS induced) asthma models encompass signifi-
cant and relevant differences in their protein patterns,
which could not be delineated by common techniques used
for characterization of airway inflammation, such as inflam-
matory cell counts and lung mechanics (Figures 2 and 3).
Using multivariate data analysis allowed for discriminating
the two asthma models from each other, as well as from
healthy control and steroid treated animals (Figures 5).
The most characteristic protein regulations associated
with neutrophilic experimental asthma included increased
levels of acute phase reactants. The adaptive immune re-
sponse is traditionally expected to be steroid sensitive,
while the innate is expected to be steroid resistant [7]. The
Th17 driven response has been suggested to play a critical
role for the innate host defence against bacteria in
mammalian lungs through its ability to indirectly mobil-
ise neutrophils [8]. In line with this, our findings show
an increased production of IL-17 as a result of the accu-
mulated neutrophils after bacterial endotoxin stimula-
tion in vivo, as well as a considerable decrease of IL-17
after steroid treatment. T cells have been reported to
release IL-17 after endotoxin exposure, but only in the
presence of macrophages [9]. IL-17 is suggested to bethe strongest recruiter of neutrophils in lung tissue. In
agreement with this, neutrophils and macrophages were
increased in BAL from the NA group compared to the
EA group (p < 0.05), in our model (Figure 3). Moreover,
neutrophils and macrophages displayed strong positive
correlations with other proteins elevated in the NA
model (Table 3). The NA model resembles severe human
asthma more than the more conventional EA model in
that it shows Th17 response related characteristics such as
IL17 expression and neutrophil recruitment. However, as
previously demonstrated for LPS induced IL17 expression,
effects of the NA model used in this study were attenuated
upon steroid treatment [10], which in turn highlights
the difficulties in creating experimental models of se-
vere steroid-resistent human asthma.
The EA group could be delineated from the NA group
based on the protein species; including TPPP3, IL-3,
IFN-γ and eotaxin, which were found significantly ele-
vated in the EA group compared to the NA group. In
asthma, it is known that reducing histone deacetylases
(HDAC) increases asthmatic inflammation and that glu-
cocorticoids down regulate the inflammatory response
in turn by modulating HDAC activity [11]. TPPP3 has
been described to inhibit HDAC [12], possibly regulating
the immune reaction towards the steroid sensitive Th2
response. Similarly, IL-3 has been associated with atopic
asthma and Th2 response [13-15].
IFN-γ is traditionally distinguished as an essential Th1
response cytokine, but has been described to have a dual
role and even protective effects in other disease models
[16]. In the present study, IFN-γ was significantly in-
creased in the EA group compared to the NA group. In
addition, IFN-γ as well as eotaxin correlated strongly
with eosinophil count.
As expected, the EA group had a marked increase of
eotaxin expression. Eotaxin selectively attracts allergic
effector cells, eosinophils and basophils, due to the
Table 3 Pearson correlation coefficients of BAL protein
levels versus inflammatory cell counts
TOTAL NEU EOS MAC LYM
S100-A9 0.732 0.898 ns 0.698 ns
CFAB ns ns ns 0.811 ns
PGAM1 ns 0.930 ns ns ns
PLMN −0.756 ns ns −0.884 ns
IGH1M 0.867 0.894 ns 0.656 0.717
PLSL ns 0.780 ns 0.621 ns
PIGR ns 0.736 ns ns 0.704
CXCL-15 ns ns ns 0.876 ns
H2B1A ns ns ns 0.710 ns
IGJ ns ns ns 0.732 ns
ECP2 ns ns ns 0.655 ns
CH3L3 0.807 ns ns 0.787 ns
FINC 0.676 0.824 ns ns 0.743
CRAMP 0.664 0.755 ns 0.767 ns
GSHR ns ns ns 0.868 ns
PGRP1 ns 0.643 ns 0.769 ns
H4 ns ns ns 0.885 ns
1433E ns ns ns 0.663 ns
CBR2 ns ns 0.818 ns −0.755
CO3 0.736 ns ns ns ns
IL-2 ns ns 0.682 ns ns
IL-9 ns ns 0.788 ns ns
IL-12p40 ns ns ns 0.716 ns
IL-13 0.771 ns ns 0.860 ns
Eotaxin 0.688 ns 0.723 ns ns
Interferon γ ns ns 0.663 ns ns
GM-CSF 0.758 ns ns 0.650 ns
MIP-1b ns ns ns 0.688 ns
TNF ns ns ns 0.679 ns
Definition of abbreviations: Neu neutrophils, Eos eosinophils, Mac
macrophages and Lym lymphocytes. R > 0.5 and R < −0.5 are considered
strong positive and negative linear correlation, respectively. Ns: no significant
correlation, p > 0.05.
Table 4 Pearson correlation coefficients of BAL protein
levels versus lung mechanics
G H RN
S100-A9 0.85 0.8 ns
PGAM1 0.92 0.88 ns
IGH1M 0.91 0.87 ns
PLSL 0.74 0.75 ns
PIGR 0.75 0.71 ns
SPA3K ns ns −0.64
CH3L3 ns ns 0.69
FINC 0.86 0.83 ns
CRAMP 0.67 0.59 ns
PGRP1 0.56 ns ns
MDHC ns ns ns
CBR2 ns ns −0.71
IL 5 ns ns 0.6
IL 12p40 0.65 0.59 0.6
IL 13 ns ns 0.93
IL 17 0.57 ns ns
RANTES 0.7 0.67 ns
Methacholine induced (3 mg/kg) tissue damping (G); tissue elastance (H) and
Newtonian resistance (RN). Regression coefficients R > 0.5 and R < −0.5 are
considered strong positive and negative linear correlation, respectively. ns: no
significant correlation, p > 0.05. Bold values indicate significant correlation
with p < 0.01.
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Its synthesis is stimulated in different cell types by IL-4,
IL-5 and IL-13, which is released mainly by Th2 lym-
phocytes [19]. Interestingly, eosinophilic cationic protein
2 (ECP2) was more pronounced in BAL from the NA
group. This protein is localised in the cytoplasmic gran-
ula of eosinophils, with the main function to selectively
attract dendritic cells to the source of infection. In spite
the low cell count of eosinophils in BAL from the NA
group, our data provide evidence that eosinophils indeed
are present, but in the case of NA instead of recruiting
more eosinophils, rather regulating the inflammation away
from a Th2 response. Group specific protein regulationsare therefore suitable markers for delineating different im-
mune response mechanisms in between these models.
Complementally lung mechanics parameters, including
elastance (H), tissue damping (G) and newtonian resist-
ance (RN), showed a significant increase in the asthma
models compared to the control group. While this veri-
fies the animal model, both lung mechanics as well as
BAL counts that are commonly used for characterizing
asthma phenotypes, did not allow delineating the asthma
models. However, correlation of lung mechanic data
with the protein regulations revealed differences in per-
ipheral and central parameters of airway responsiveness
(Table 4). Here, strong correlation of peripheral parame-
ters, elastance and tissue damping, correlated strongly
with proteins elevated in NA. These correlations were
found to be very similar to protein correlations observed
for neutrophil and macrophage cell counts. Indeed, direct
correlation analysis revealed a strong positive correlation
for G (R = 0.99) and H (R = 0.97) with recruited neutro-
phils but not for other BAL cells. Conversely, Newtonian
resistance as a central parameter for airway responsiveness
displayed no correlation with any inflammatory cell count.
This supports the theory that lung mechanics in the per-
ipheral airways plays an important role in asthma patho-
physiology due to exaggerated airway closure [20]. Thus,
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reflected peripheral airway closure. If confirmed, these
proteins could serve as biomarkers indicating inflamma-
tion of distal airways.
Moreover, RN was found to correlate with chitinase 3,
a common biomarker in asthma. Chitinase 3 did not dif-
ferentiate the two models of inflammation, although it
has been suggested to play a key role in Th2 driven in-
flammatory response [21]. Similarly, further Th2 associ-
ated proteins, IL-5 and IL-13, correlated positively with
RN. This suggests that commonly used markers for
asthma, including IL-13 and chitinase, do in fact only re-
flect central airway inflammation.
Conclusion
We employed an integrative multi-modal proteomic ap-
proach based on LC-FTICR-MS and Bio-Plex™ analysis
for quantitative protein profiling of BAL samples in
murine models of eosinophilic and neutrophilic asthma.
The results show significant changes in protein expres-
sion between eosinophilic and neutrophilic murine
asthma groups. These protein species may help to char-
acterise the different phenotypes as well as the predom-
inant mechanisms involved, particularly with respect to
different T-lymphocyte mediated mechanisms in respira-
tory inflammation. Furthermore, the observed group-
specific proteomic fingerprints can be used to characterise
the specific patterns of clinical presentation and may be
useful for future diagnosis, prediction of clinical outcomes
and treatment guidance. In summary, most of the conven-
tional inflammatory markers measured by the commercial
Bio-Plex™ technique were increased in BAL from the EA
group. In contrast, most of the proteins we could detect
and quantify with LC-FTICR-MS were more prominent in
the NA group. In addition, major inflammation markers
were correlated to peripheral airway closure, while com-
monly used asthma biomarkers only reflect central inflam-
mation. Therefore, our data suggest that the commercial
markers we are currently relying on to diagnose asthma
subtypes are not giving us comprehensive or specific
enough information.Additional files
Additional file 1: Table S1. Protein identified in BAL using mass
spectrometry based proteomics. All proteins were identified at 95%
significance level with at least 2 peptides. Accession Uniprot
knowledgebase v.56 www.uniprot.org.
Additional file 2: Figure S1. Protein changes as detected by means of
mass spectrometry based proteomics. Statistical significance (p < 0.05) is
indicated with * OVA/LPS vs C; # OVA/LPS vs OVA/OVA; % OVA/LPS vs
OVA/LPS/GC and &OVA/OVA vs C. Figure S2. Protein changes as
detected by means of Bio-Plex analysis. Statistical significance (p < 0.05) is
indicated with * OVA/LPS vs C; # OVA/LPS vs OVA/OVA; % OVA/LPS vs
OVA/LPS/GC and &OVA/OVA vs C.Abbreviations
BAL: Bronchoalveolar lavage; EA: Eosinophilic asthma; NA: Neutrophilic
asthma; OVA: Ovalbumin; LPS: Lipopolysaccharide; GC: Glucocorticoid;
LC: Liquid chromatography; ESI: Electrospray ionization; FT: Fourier transform;
MS: Mass spectrometry.
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